Minerva Neurosciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.

About NERV

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.

CEO

Rémy Henri Luthringer

CEORémy Henri Luthringer

Employees

Employees8

Headquarters

Burlington, Massachusetts

HeadquartersBurlington, Massachusetts

Founded

2007

Founded2007

Employees

Employees8

NERV Key Statistics

Market cap

11.26M

Market cap11.26M

Price-Earnings ratio

9.00

Price-Earnings ratio9.00

Dividend yield

—

Dividend yield—

Average volume

7.14K

Average volume7.14K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$3.69

52 Week high$3.69

52 Week low

$1.15

52 Week low$1.15

People also own

Based on the portfolios of people who own NERV. This list is generated using Robinhood data, and it’s not a recommendation.